Adenosine cycle in African trypanosomes.

Area of Science:

• Biochemistry
• Parasitology
• Drug Discovery

Background:

• African trypanosomes, the causative agents of sleeping sickness, possess unique metabolic pathways.
• Understanding these pathways is crucial for developing effective treatments against trypanosomiasis.

Purpose of the Study:

• To elucidate the metabolic fate of adenosine in different species of African trypanosomes.
• To determine the enzymatic mechanisms involved in adenosine conversion to adenosine monophosphate (AMP).
• To assess the implications of these metabolic differences for the efficacy of adenosine analogue therapies.

Main Methods:

• Enzymatic assays to measure adenosine and adenine conversion.
• Identification of key enzymes like purine nucleoside hydrolase, purine nucleoside phosphorylase, and adenine phosphoribosyltransferase.
• Comparative analysis of metabolic pathways across *Trypanosoma brucei*, *T. vivax*, and *T. congolense*.

Main Results:

• African trypanosomes convert adenosine to AMP, but most adenosine is first broken down to adenine in *T. brucei*, *T. vivax*, and *T. congolense*.
• *T. brucei* and *T. vivax* utilize purine nucleoside hydrolase for adenosine cleavage, while *T. congolense* uses purine nucleoside phosphorylase.
• *T. vivax* further deaminates adenine to hypoxanthine, preceding AMP synthesis.
• All studied African trypanosomes lack adenosine deaminase.

Conclusions:

• Significant metabolic heterogeneity exists in adenosine processing among African trypanosome species.
• The absence of adenosine deaminase and varied enzymatic routes for adenine conversion are key findings.
• Therapeutic strategies using adenosine analogue drugs for African trypanosomiasis must consider the specific trypanosome strain's metabolic profile for optimal effectiveness.